The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Vitamin D and fibromyalgia: a meta-analysis

  • Makrani, Atekeh Hadinezhad (Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences) ;
  • Afshari, Mahdi (Department of Community Medicine, Zabol University of Medical Sciences) ;
  • Ghajar, Marayam (Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences) ;
  • Forooghi, Zahra (Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences) ;
  • Moosazadeh, Mahmood (Health Science Research Center, Addiction Institute, Mazandaran University of Medical Sciences)
  • Received : 2017.06.16
  • Accepted : 2017.08.25
  • Published : 2017.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Vitamin D is a cofactor responsible for autoimmune disorders. There is no agreement in the studies investigating the association between vitamin D and fibromyalgia. This study aims to combine the conflicting results of the primary studies which compared these patients with control groups regarding the serum concentration of vitamin D. This meta-analysis has been designed based on PRISMA guidelines. Relevant keywords were searched in PubMed, Science direct, Scopus, Cochrane, and Google scholar and primary studies were selected. After screening the eligible studies according to inclusion/exclusion criteria, we investigated the risk of bias in the selected studies and also the heterogeneity between the primary results using Cochrane (Q) and I-squared ($I^2$) indices. The primary results were combined using inverse variance method and Cohen statistics as well as a random effects model. Publication bias was assessed using Egger test. Sensitivity analysis was applied to investigate the influence of each primary study on the final result of the meta-analysis. Suspected factors in the heterogeneity were assessed using meta-regression models. We entered 12 eligible studies in the meta-analysis including 851 cases compared with 862 controls. The standardized mean difference of Vitamin D between the two groups was -0.56 (95% confidence interval: -1.05, -0.08). Our meta-analysis showed that vitamin D serum levels of patients with fibromyalgia was significantly lower than that of control group.

Keywords

References

  1. Olama SM, Senna MK, Elarman MM, Elhawary G. Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia. Rheumatol Int 2013; 33: 185-92. https://doi.org/10.1007/s00296-012-2361-0
  2. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72. https://doi.org/10.1002/art.1780330203
  3. Okyay R, Kocyigit B, Gursoy S. Vitamin D levels in women with fibromyalgia and relationship between pain, tender point count and disease activity. Acta Med Mediterr 2016; 32: 243-7.
  4. Labeeb AA, Al-Sharaki DR. Detection of serum 25(OH)-vitamin D level in the serum of women with fibromyalgia syndrome and its relation to pain severity. Egypt Rheumatol Rehabil 2015; 42: 196-200. https://doi.org/10.4103/1110-161X.168202
  5. Baygutalp NK, Baygutalp F, Seferoglu B, Bakan E. The relation between serum vitamin D levels and clinical findings of fibromyalgia syndrome. Dicle Med J 2014; 41: 446-50. https://doi.org/10.5798/diclemedj.0921.2014.03.0452
  6. Abokrysha NT. Vitamin D deficiency in women with fibromyalgia in Saudi Arabia. Pain Med 2012; 13: 452-8. https://doi.org/10.1111/j.1526-4637.2011.01304.x
  7. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 2007; 146: 726-34. https://doi.org/10.7326/0003-4819-146-10-200705150-00006
  8. Wood PB, Holman AJ, Jones KD. Novel pharmacotherapy for fibromyalgia. Expert Opin Investig Drugs 2007; 16: 829-41. https://doi.org/10.1517/13543784.16.6.829
  9. Bergman S. Management of musculoskeletal pain. Best Pract Res Clin Rheumatol 2007; 21: 153-66. https://doi.org/10.1016/j.berh.2006.10.001
  10. Arnold LM, Clauw DJ, Dunegan LJ, Turk DC; FibroCollaborative. A framework for fibromyalgia management for primary care providers. Mayo Clin Proc 2012; 87: 488-96. https://doi.org/10.1016/j.mayocp.2012.02.010
  11. Bhatty SA, Shaikh NA, Irfan M, Kashif SM, Vaswani AS, Sumbhai A, et al. Vitamin D deficiency in fibromyalgia. J Pak Med Assoc 2010; 60: 949-51.
  12. Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hypponen E. Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Ann Rheum Dis 2009; 68: 817-22. https://doi.org/10.1136/ard.2008.090456
  13. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78: 1463-70. https://doi.org/10.4065/78.12.1463
  14. Altindag O, Ogut E, Gur A, Gursoy S, Gunay M. Serum vitamin D level and its relation with clinical parameters in fibromyalgia as a neuropathic pain. Orthop Muscular Syst 2014; 3: 171.
  15. Ulusoy H, Sarica N, Arslan S, Ozyurt H, Cetin I, Birgul Ozer E, et al. Serum vitamin D status and bone mineral density in fibromyalgia. Bratisl Lek Listy 2010; 111: 604-9.
  16. Okumus M, Koybasi M, Tuncay F, Ceceli E, Ayhan F, Yorgancioglu R, et al. Fibromyalgia syndrome: is it related to vitamin D deficiency in premenopausal female patients? Pain Manag Nurs 2013; 14: e156-63. https://doi.org/10.1016/j.pmn.2011.09.006
  17. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12. https://doi.org/10.1016/j.jclinepi.2009.06.005
  18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74. https://doi.org/10.2307/2529310
  19. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [Internet]. London: The Cochrane Collaboration; 2011 [cited 2011 March 3]. Available at http://handbook.cochrane.org.
  20. Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2012 [cited 2012 March 8]. Available at https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0077771/.
  21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58. https://doi.org/10.1002/sim.1186
  22. Al-Allaf AW, Mole PA, Paterson CR, Pullar T. Bone health in patients with fibromyalgia. Rheumatology (Oxford) 2003; 42: 1202-6. https://doi.org/10.1093/rheumatology/keg356
  23. Maafi AA, Ghavidel-Parsa B, Haghdoost A, Aarabi Y, Hajiabbasi A, Shenavar Masooleh I, et al. Serum vitamin D status in Iranian fibromyalgia patients: according to the symptom severity and illness invalidation. Korean J Pain 2016; 29: 172-8. https://doi.org/10.3344/kjp.2016.29.3.172
  24. Balkarli A, Balkarli H, Temel S, Ozhan N, Ozkan U, Cobankara V. AB0656 Serum vitamin D and parathyroid hormone levels in premenopausal women with fibromyalgia syndrome. Ann Rheum Dis 2013; 72: A989.
  25. Mateos F, Valero C, Olmos JM, Casanueva B, Castillo J, Martinez J, et al. Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia. Osteoporos Int 2014; 25: 525-33. https://doi.org/10.1007/s00198-013-2434-2
  26. Monteiro DM. Evaluation of vitamin D status in a population with fibromyalgia [master thesis]. Coimbra: Univ. of Coimbra, 2011.
  27. Ozcan DS, Oken O, Aras M, Koseoglu BF. Vitamin D levels in women with fibromyalgia and relationship between pain, depression, and sleep. Turk J Phys Med Rehabil 2014; 60: 329-34. https://doi.org/10.5152/tftrd.2014.45143
  28. de Rezende Pena C, Grillo LP, das Chagas Medeiros MM. Evaluation of 25-hydroxyvitamin D serum levels in patients with fibromyalgia. J Clin Rheumatol 2010; 16: 365-9. https://doi.org/10.1097/RHU.0b013e3181fe8a90
  29. Tandeter H, Grynbaum M, Zuili I, Shany S, Shvartzman P. Serum 25-OH vitamin D levels in patients with fibromyalgia. Isr Med Assoc J 2009; 11: 339-42.

Cited by

  1. Intestinal dysbiosis and hormonal neuroendocrine secretion in the fibromyalgic patient: Relationship and correlations pp.18047521, 2018, https://doi.org/10.5507/bp.2018.051
  2. Effect of Vitamin D Deficiency on the Frequency of Headaches in Migraine vol.14, pp.3, 2018, https://doi.org/10.3988/jcn.2018.14.3.366
  3. Association of ferritin levels with depression, anxiety, sleep quality, and physical functioning in patients with fibromyalgia syndrome: a cross-sectional study vol.60, pp.6, 2017, https://doi.org/10.3325/cmj.2019.60.515
  4. Comparison between Acupuncture and Nutraceutical Treatment with Migratens ® in Patients with Fibromyalgia Syndrome: A Prospective Randomized Clinical Trial vol.12, pp.3, 2020, https://doi.org/10.3390/nu12030821
  5. Fibromyalgia syndrome and the eye—A review vol.66, pp.1, 2021, https://doi.org/10.1016/j.survophthal.2020.05.006
  6. Nociception: the roles of vitamin D vol.13, pp.1, 2021, https://doi.org/10.14412/2074-2711-2021-1-145-153
  7. The Role of Nutrient Supplementation in the Management of Chronic Pain in Fibromyalgia: A Narrative Review vol.10, pp.2, 2017, https://doi.org/10.1007/s40122-021-00266-9
  8. Association of asthma with low serum vitamin D and its related musculoskeletal and psychological symptoms in adults: a case-control study vol.31, pp.1, 2021, https://doi.org/10.1038/s41533-021-00239-7